Yinglian Pharmaceutical Holdings Group

Yinglian Pharmaceutical Holdings Group appears to be a pharmaceutical holding and commercial operations group rather than a discovery-stage biotech developer. Publicly available information indicates it was affiliated with Sino Health Pharmaceutical Limited and related subsidiaries including Ying Lian Zhuhai and Ying Lian Germany, which were involved in marketed products and a China NDA-stage asset. The group seems to have focused on pharmaceutical commercialization, hospital and retail distribution, and supply-chain capabilities in China rather than a disclosed proprietary R&D platform. Evidence from later web sources also suggests a connection to Georgetown/George Town Pharmacal-branded operations focused on branded and generic hospital products such as sterile IV solutions, infusion systems, parenteral nutrition, anaesthetics, antibiotics, and related medical products. Overall, this looks like a healthcare-related pharmaceutical group with commercial assets, but with limited transparent public disclosure on corporate structure, ownership, and pipeline specifics.